Atlas Trials

Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers

Clinical trial NCT04330716 · COMPLETED

Trial details

NCT number
NCT04330716
Sponsor
Dana-Farber Cancer Institute
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast CancerOvarian CancerPancreatic CancerMetastatic Prostate Cancer
Start date
2020-12-01
Primary completion
2023-12-31
Enrollment
269

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.